Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD
Braintree Laboratories, a part of Sebela Pharmaceuticals and a leading manufacturer of gastroenterology pharmaceutical products, announced positive topline results from two pivotal US phase 3 clinical trials evaluating tegoprazan, a novel potassium- …